Therefore, either STAT3 could generate paracrine signals capable of inhibiting NFκB activation; or tumors could inhibit NFκB, through other mechanisms that do not directly involve STAT3, but that were reduced as treatment with STAT3 inhibition reduced tumor growth. The gene discussed is STAT3; the disease is neoplasm.